Klickitat Valley Health (KVH) has expanded its Outpatient Respiratory Therapy Services, enhancing access to advanced lung and breathing care for patients in Klickitat County and surrounding ...

The 3TR project aims to transform the understanding and treatment of immune-mediated diseases, with its core principles in ...

GSK now has the global development and commercialisation rights to the COPD-targeting oligonucleotide, EMP-012.

The drug dupilumab (Dupixent) effectively clears up airways plugged by mucus during an asthma attack, researchers reported ...

Cash generated from operations totaled £2.5 billion, with free cash flow of £1.2 billion. GSK declared a dividend of 16 pence ...

GSK and Empirico ink license agreement for clinical-stage, first-in-class oligonucleotide candidate to treat respiratory diseases: London, UK Wednesday, October 29, 2025, 09:00 Hr ...

For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to the intensive care unit ...

Rule changes mean people aged 65 to 74 who do not have a serious illness are no longer eligible for free NHS covid jabs - ...

GSK is shelling out $85 million up front, and possibly $745 million overall, for an RNA-based therapy it sees helping a ...

Merck MRK will report its third-quarter 2025 earnings on Oct. 30, before market open. The Zacks Consensus Estimate for ...

Shortness of breath when walking short distances can occur suddenly or be a chronic condition. It should be evaluated, as it ...